Pharmaceuticals, Biotechnology and Life Sciences
WASHINGTON–(BUSINESS WIRE)–Today, the Biotechnology Institute announced the winner of the BioGENEius Hall of Fame Award, who will be recognized next…
New technology innovations mark the company’s next milestones, and build on its pioneering history ATLANTA–(BUSINESS WIRE)–SCIEX, a global leader in…
22% of Patients Receiving LYNPARZA Remained Progression-Free After Two Years vs. 10% on Placebo, Following Platinum-Based Chemotherapy AstraZeneca and Merck’s…
LISBON, Portugal–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today presented topline results…
BOSTON & LOUISVILLE, Ky.–(BUSINESS WIRE)–Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential…
— Data Show High Rates of Response to Single Infusion of KTE-X19 — — Phase 2 Portion of ZUMA-3 is…
Tumor regressions demonstrate potential for DPX-Survivac immunotherapy in hard-to-treat solid tumors Data correlations of survivin specific T cell levels and…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative…
WASHINGTON–(BUSINESS WIRE)–Today, the Biotechnology Institute announced the winner of the Mentor of the Year Award, who will be recognized next…
Data show the potential of using neoantigens identified from an individual’s tumor to elicit an immune response to cancer mutations…